Title: Atrial Fibrillation Market Demand and Production Overview 2017 to 2026
1Product Type - EP Ablation Catheters, EP
Diagnostic Catheters, EP Mapping Recording
Systems, Cardiac Monitors, Access Devices, LAA
Closure, Other Products End User - Hospitals,
Electrophysiology Labs, Ambulatory Surgical
Center Application - Diagnostic, EP Ablation,
SurgicalForecast From 2017 - 2026
Atrial Fibrillation Market
2Table of Content
Sr. No. Content
Chapter1 Global Atrial Fibrillation Market - Executive Summary
Chapter 2 Global Atrial Fibrillation Market Overview
Chapter 3 Global Atrial Fibrillation Market Analysis and Forecast 2012-2026
Chapter 4 North America Atrial Fibrillation Market Size and Forecast, 2012-2026
Chapter 5 Latin America Atrial Fibrillation Market Size and Forecast, 2012-2026
Chapter 6 Europe Atrial Fibrillation Market Size and Forecast, 2012-2026
Chapter 7 Japan Atrial Fibrillation Market Size and Forecast, 2012-2026
Chapter 8 APEJ Atrial Fibrillation Market Size and Forecast, 2012-2026
Chapter 9 MEA Atrial Fibrillation Market Size and Forecast, 2012-2026
Chapter 10 Global Atrial Fibrillation Market Company Share, Competition Landscape and Company Profiles
Chapter 11 Research Methodology
Chapter 12 Secondary and Primary Sources
Chapter 13 Assumptions and Acronyms
Chapter 14 Disclaimer
3Atrial Fibrillation Market Snapshot
- Growing incidence of obesity, hypertension, and
diabetes has also resulted in different heart
diseases leading the growth in the global atrial
fibrillation. - Increasing medical research and development
activities and advancement seen in treatment and
diagnoses of atrial fibrillation are also
expected to expand the global atrial fibrillation
market in the forthcoming years. - The global atrial fibrillation market is
categorized on the basis of product type, end
user, and application. - The application of atrial fibrillation is seen in
surgical, EP ablation, and diagnostics. Of these,
the EP ablation segment is expected to hold
larger share in the global atrial fibrillation
market.
4(No Transcript)
5Reports Highlights
- Global atrial fibrillation market is likely to
progress at 11.0 CAGR between 2017 and 2026.
Rising at this rate, the market is expected to
reach US10.92 bn by the end of 2026. - Leading players including Biosense Webster, Inc.,
Medtronic Plc, Abbott Laboratories, Osypka AG,
Biotronik SE Co. KG, Boston Scientific
Corporation, AtriCure Inc., MicroPort Scientific
Corporation, CardioFocus, Inc., and Koninklijke
Philips N.V.
Request Sample
6(No Transcript)